We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $14.8M invested in Aptevo Therapeutics in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more capital invested

Capital invested by funds: $9.35M → $14.8M (+$5.4M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$675K
Puts
Net Calls
+$675K
Net Calls Change
+$675K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$3.5M
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$1.98M
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.34M
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$1.19M
Renaissance Technologies
5
Renaissance Technologies
New York
$1.11M
SC
6
Sessa Capital
New York
$920K
PWAM
7
Park West Asset Management
California
$900K
CH
8
CVI Holdings
Delaware
$703K
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$631K
6CM
10
683 Capital Management
New York
$518K
WVP
11
Worth Venture Partners
New Jersey
$387K
BlackRock
12
BlackRock
New York
$319K
Millennium Management
13
Millennium Management
New York
$154K
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$138K
SIM
15
Spark Investment Management
New York
$123K
Geode Capital Management
16
Geode Capital Management
Massachusetts
$102K
BCM
17
Bridgeway Capital Management
Texas
$85K
CL
18
CSS LLC
Illinois
$78K
Deutsche Bank
19
Deutsche Bank
Germany
$64K
QI
20
QS Investors
New York
$57K
BFM
21
Boothbay Fund Management
New York
$54K
Northern Trust
22
Northern Trust
Illinois
$54K
ACA
23
Atlas Capital Advisors
Wyoming
$44.1K
UBS Group
24
UBS Group
Switzerland
$43K
ARTA
25
A.R.T. Advisors
New York
$39K